Bluejay Diagnostics, Inc. (BJDX) stock
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.15−0.14 (-5.90%)
Close on Nov 17, 2026Market cap $9.63MP/E –Yield –
Bluejay Diagnostics gross margin
Gross margin is gross profit as a percentage of revenue.
Bluejay Diagnostics's gross margin for the twelve months ending Dec 31, 2022 was 19.6%. For fiscal 2022 it was 19.6%.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 19.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | 19.6% | – |
See a number that looks wrong?